LUCID DIAGNOSTICS
Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company. Lucid is focused on the millions of patients with gastroesophageal disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid’s EsoGuard® Esophageal DNA Test, performed on samples collected in a brief noninvasive office procedure with its EsoCheck® Esophageal Cell Collection Device, is the first and only commercially available diagnostic test capable of serving as a widespread screening tool to prevent cancer and cancer deaths through early detection of esophageal precancer in at-risk GERD patients.
LUCID DIAGNOSTICS
Industry:
Health Care Health Diagnostics Therapeutics
Founded:
2018-05-30
Status:
Active
Contact:
2129494319
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Apache Euro Amazon GStatic Google Static Content COVID-19
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-10-07 | CapNostics | CapNostics acquired by Lucid Diagnostics | N/A |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-21 | Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer |